Simulation of bempedoic acid and ezetimibe in the lipid-lowering treatment pathway in Austria using the contemporary SANTORINI cohort of high and very high risk patients

OBJECTIVE: The low-density lipoprotein cholesterol goals in the 2019 European Society of Cardiology/European Atherosclerosis Society dyslipidaemia guidelines necessitate greater use of combination therapies. We describe a real-world cohort of patients in Austria and simulate the addition of oral bem...

Descripción completa

Detalles Bibliográficos
Autores principales: Toplak, Hermann, Bilitou, Aikaterini, Alber, Hannes, Auer, Johann, Clodi, Martin, Ebenbichler, Christoph, Fließer-Görzer, Evelyn, Gelsinger, Carmen, Hanusch, Ursula, Ludvik, Bernhard, Maca, Thomas, Schober, Andreas, Sock, Reinhard, Speidl, Walter S., Stulnig, Thomas M., Weitgasser, Raimund, Zirlik, Andreas, Koch, Marina, Wienerroither, Sebastian, Wolowacz, Sorrel E., Diamand, Françoise, Catapano, Alberico L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338584/
https://www.ncbi.nlm.nih.gov/pubmed/37286910
http://dx.doi.org/10.1007/s00508-023-02221-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338584/
https://www.ncbi.nlm.nih.gov/pubmed/37286910
http://dx.doi.org/10.1007/s00508-023-02221-4

Ejemplares similares